Newleos
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
800 Boylston St Ste 1715, Boston, Massac...Website
www.newleos.comRevenue
$5.7 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Newleos
Newleos Therapeutics is a clinical-stage neuroscience company dedicated to developing next-generation, first- and best-in-class therapies for mental health conditions. Co-founded by Longwood Fund and experienced leaders in central nervous system (CNS) drug development, Newleos has in-licensed a clinical-stage pipeline from Roche. This pipeline includes multiple oral small molecules targeting novel mechanisms across a broad range of indications, such as generalized anxiety, social anxiety, substance use disorders, and cognitive impairment.Explore more
Newleos Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Newleos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Newleos had a recent Job posting/layoffs
Check if Newleos has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Newleos
Earning: See what the market has to say on Newleos recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Newleos has new funding data
Newleos, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Newleos is spiking on competitors!
Product Launch: Get notified when Newleos launches new products
Recommended Actions
Reach out to Masked Content who joined Newleos as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Newleos is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Newleos is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Newleos.
Newleos financials insights
Gather financial insights about Newleos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Series A
$93.5M
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Newleos News & Media
Newleos Therapeutics Announces Clinical Advisory Board to Support Key Neuropsychiatry Programs
BOSTON--(BUSINESS WIRE)-- #AnxietyDisorders--Newleos Therapeutics, Inc., a clinical-stage neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug development, today announced the inaugural members of its Clinical Advisory Board to support the development of its neuropsychiatric product pipeline, including NTX-1955 for generalized anxiety disorder and NTX-1472 for social anxiety disorder. Members of the Clinical Advisory Board are internationally recognized leaders in psNewleos Therapeutics Expands Leadership Team to Advance its Clinical-Stage Neuropsychiatric Programs and Drive Corporate Growth
BOSTON--(BUSINESS WIRE)-- #Biotech--Newleos Therapeutics expanded its leadership team with the appointment of experienced professionals across clinical, medical, and corporate functions.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Newleos
Sign Up For FreeTo access detailed company insights
Newleos Therapeutics is a clinical-stage neuroscience company dedicated to developing next-generation, first- and best-in-class therapies for mental health conditions. Co-founded by Longwood Fund and experienced leaders in central nervous system (CNS) drug development, Newleos has in-licensed a clinical-stage pipeline from Roche. This pipeline incl... Read More
